Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
The global market for antibiotics was valued at $39.2 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 4.2% to reach $49.6 billion by the end of 2027.
The antibiotic market growth outlook is positive with significant growth potential for cell wall inhibitor and protein inhibitor antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobialresistant drugs at affordable prices.
At the same time, factors such as rising disposable incomes and increasing spending on healthcare in emerging markets, increasing grants from government agencies for antibiotic drugs R&D and rising incidence of infectious diseases are contributing to the growth of the market.
Pharmaceutical companies and governments are increasingly working together in partnerships and collaborations to provide funding and to implement incentive programs for the R&D of antibiotics. These partnerships provide financial and technical assistance across different clinical development phases.
Various programs, such as the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), the Innovative Medicines Initiative's (IMI's) New Drugs for Bad Bugs (ND4BB) program, Biomedical Advanced Research and Development Authority's (BARDA) Broad Spectrum Antimicrobials Program and Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), have been implemented for the development of novel antibiotics by focusing on R&D gaps.
Additionally, The Davos Declaration was signed in Jan. 2016 by more than 100 companies and trade associations (Allergan, AstraZeneca, GSK, Pfizer and Sanofi). This declaration focused on investments in R&D to meet public health needs, reducing the development of antimicrobial resistance and improving access to antibiotics.
Pharmaceutical companies are increasingly adopting 3D printing technology for the discovery and development of new antibiotics to reduce manufacturing costs and increase production efficiency. In 2018, a 3D-printed fluorescence imaging box (PFIbox) was developed by McMaster University's laboratory for antibiotics discovery. This box is capable of analyzing more than 6,000 samples of bacteria at a time and provides vital information on bacterial response.
The report segments the market for antibiotics based on product type, route of administration, application and geographical region. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA and other inhibitors (RNA, mycolic acid, folic acid). Based on route of administration, the market is segmented into oral and topical.
By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, South America and the Middle East and Africa. Detailed analysis of major countries (U.S., Germany, UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa) will be covered in the regional segment. For market estimates, data will be provided for 2021 as the base year, with estimates for 2022 and forecast value for 2027.
Report Includes
- An overview of the global market for antibiotics within the pharmaceutical industry
- Analyses of the global market trends, with data corresponding to market size for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
- Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user, and geographical region
- Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
- Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value (USD) in 2022 | $40.4 Billion |
| Forecasted Market Value (USD) by 2027 | $49.6 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Dynamics
- Market Drivers
- Growth Driven by Antibiotics
- Rising Elder Population and Infection Rate
- Increasing Hospital-Acquired Infections
- Improved Awareness
- Market Restraints
- Antibiotic-Resistant Infections
- Generics
- Declining R&D Investment
- Side Effects of Antibiotics
- Market Opportunities
- Market Expansion
- Novel Antibacterial Agents
Chapter 5 Market Breakdown, by Product
Chapter 6 Market Breakdown, by Route of Administration
Chapter 7 Market Breakdown, by Region
Chapter 8 Impact of Covid-19 on the Pharmaceutical Industry
Chapter 9 Clinical Developments and Pipeline Products
Chapter 10 Value Chain Analysis
Chapter 11 Regulatory Scenario
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
Chapter 14 Appendix: Acronyms
Companies Mentioned
- Abbott
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Sanofi
- Viatris Inc.
For more information about this report visit https://www.researchandmarkets.com/r/hnm4at
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
